Skip to main content
Log in

The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Several reports have shown a better prognosis in gastric cancer patients who are positive for Helicobacter pylori (HP) infection compared with negative cases. However, there are currently no studies that investigate the relationship between HP infection and the effects of chemotherapy in gastric cancer patients. In this study, we report the relationship between HP infection and chemotherapy effects in patients with advanced or metastatic gastric cancer.

Methods

Sixty-one patients with advanced or metastatic gastric cancer were enrolled in this study. Biopsies were conducted around the tumor site to determine HP status. Patients were then treated with combination 5-FU and cisplatin-based chemotherapy. And we compared chemotherapy response rate and overall survival rate between HP infection group and without HP infection group.

Results

Twelve of 18 patients with HP infection (66.7 %) and 9 of 42 patients without HP infection (21.4 %) showed a partial response to chemotherapy (Chi square P = 0.001). Patients with HP infection had a median survival time of 13 months (95 % CI, 6.9–19.1 months), which was significantly longer than that of patients without HP infection (9 months; P = 0.027, log-rank test).

Conclusions

Patients with advanced or metastatic gastric cancer with concomitant HP infection had a better response to chemotherapy and had an improved overall prognosis compared with patients without HP infection. Further studies are warranted to confirm these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Nomura AM, Kolonel LN, Miki K et al (2005) Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J Infect Dis 191:2075–2081

    Article  PubMed  CAS  Google Scholar 

  2. Meimarakis G, Winter H, Assmann I et al (2006) Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol 7:211–222

    Article  PubMed  Google Scholar 

  3. Marrelli D, Pedrazzani C, Berardi A et al (2009) Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer 115:2071–2080

    Article  PubMed  CAS  Google Scholar 

  4. Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 20:1161–1181

    Google Scholar 

  5. Stadtlander CT, Waterbor JW (1999) Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20:2195–2208

    Article  PubMed  CAS  Google Scholar 

  6. Hansson LE, Engstrand L, Nyren O et al (1993) Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 105:1098–1103

    PubMed  CAS  Google Scholar 

  7. Chow WH, Blaser MJ, Blot WJ et al (1998) An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58:588–590

    PubMed  CAS  Google Scholar 

  8. Ohno S, Tomisaki S, Oiwa H et al (1995) Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 180:577–582

    PubMed  CAS  Google Scholar 

  9. Helicobacter and Cancer Collaboration Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347–353

    Google Scholar 

  10. Malaty HM, Kim JG, Kim SD, Graham DY (1996) Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol 143:257–262

    Article  PubMed  CAS  Google Scholar 

  11. Lee HJ, Yang HK, Ahn YO (2002) Gastric cancer in Korea. Gastric Cancer 5:177–182

    Article  PubMed  Google Scholar 

  12. Kohli Y, Tanaka Y, Kato T, Ito S (1993) Endoscopic diagnosis of Helicobacter pylori distribution in human gastric mucosa by phenol red dye spraying method. Nihon Rinsho 51:3182–3186

    PubMed  CAS  Google Scholar 

  13. Iseki K, Tatsuta M, Iishi H, Baba M, Ishiguro S (1998) Helicobacter pylori infection in patients with early gastric cancer by the endoscopic phenol red test. Gut 42:20–23

    Article  PubMed  CAS  Google Scholar 

  14. Araujo-Filho I, Brandao-Neto J, Pinheiro LA, Azevedo IM, Freire FH, Medeiros AC (2006) Prevalence of Helicobacter pylori infection in advanced gastric carcinoma. Arq Gastroenterol 43:288–292

    Article  PubMed  Google Scholar 

  15. Caruso ML, Fucci L (1990) Histological identification of Helicobacter pylori in early and advanced gastric cancer. J Clin Gastroenterol 12:601–602

    PubMed  CAS  Google Scholar 

  16. Tang YL, Gan RL, Dong BH, Jiang RC, Tang RJ (2005) Detection and location of Helicobacter pylori in human gastric carcinomas. World J Gastroenterol 11:1387–1391

    PubMed  Google Scholar 

  17. Hobsley M, Tovey FI, Holton J (2007) Helicobacter pylori and gastric cancer: neither friend nor foe. Gastroenterology 132:2076

    Article  PubMed  Google Scholar 

  18. Qiu HB, Zhang LY, Keshari RP et al (2010) Relationship between H. pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer 10:374

    Article  PubMed  Google Scholar 

  19. Kang SY, Han JH, Ahn MS et al. (2012) Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection. Int J Cancer 130:948–958

    Google Scholar 

  20. Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269

    Article  PubMed  CAS  Google Scholar 

  21. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM (2001) Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125:1–9

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a Korea University Grant.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jae Hong Seo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, I.K., Sung, H.J., Lee, JH. et al. The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer. Cancer Chemother Pharmacol 70, 555–558 (2012). https://doi.org/10.1007/s00280-012-1944-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-012-1944-5

Keywords

Navigation